Sensus Healthcare Analyst Price Targets - Benzinga

Sensus Healthcare Inc

SRTSNASDAQ

Trade with Public

Trade with Public

$3.47

0.216.44%

Last update: Sep 1, 9:30 AM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Sensus Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sensus Healthcare (SRTS).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$7Upside to Avg. PT+87.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Lake Street	Ben Haynor	PT Cut	Buy	$5→$4
Feb 17, 2026	Maxim Group	Anthony Vendetti	PT Cut	Buy	$8→$6
Aug 15, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$10→$8
Aug 12, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$12→$8
Aug 8, 2025	Lake Street	Ben Haynor	PT Cut	Buy	$13→$6
May 27, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$11→$10
May 19, 2025	Maxim Group	Anthony Vendetti	PT Cut	Buy	$14→$10
Apr 4, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$12
Mar 11, 2025	Lake Street	Ben Haynor	PT Cut	Buy	$18→$13
Feb 10, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$11→$12
Nov 18, 2024	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$10→$11
Nov 15, 2024	Maxim Group	Anthony Vendetti	PT Raise	Buy	$12→$14
Aug 12, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$10
May 13, 2024	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$8→$10
May 10, 2024	Maxim Group	Anthony Vendetti	PT Raise	Buy	$7→$10
Nov 13, 2023	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$8

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $4

Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $4.5 to $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Lowers Price Target to $8

HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $12 to $8.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $6

Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $13 to $6.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on Sensus Healthcare, Lowers Price Target to $10

Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $14 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $12 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ:SRTS) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $13

Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $18 to $13.

Benzinga Newsdesk